Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


VASCULAR GRAFT OCCLUSION side effect

What is VASCULAR GRAFT OCCLUSION ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   VASCULAR GRAFT OCCLUSION and Recently Reported Side Effects   VASCULAR GRAFT OCCLUSION and 15 most Active Side Effect polls   VASCULAR GRAFT OCCLUSION and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with VASCULAR GRAFT OCCLUSION

ANGIOMAX  APROTININ  CILOSTAZOL  NIASTASE  PLAVIX  TRASYLOL  


Niastase Side Effects Report #5656770-8
Physician from CANADA reported NIASTASE problem on Mar 05, 2008. Male patient was treated with NIASTASE. After drug was administered, patient experienced the following problems/side effects: vascular graft occlusion, . NIASTASE dosage: unknown. Patient died.

Cilostazol Side Effects Report #5536967-8
CILOSTAZOL problem was reported by a Physician from GERMANY on Nov 20, 2007. Female patient, 80 years of age, was diagnosed with intermittent claudication and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: vascular graft occlusion, . CILOSTAZOL dosage: 200 MG, ORAL. During the same period patient was treated with RAMIPRIL, NEBIVOLOL, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Cilostazol Side Effects Report #5582949-X
Consumer or non-health professional from GERMANY reported CILOSTAZOL problem on Dec 17, 2007. Female patient, 56 years of age, was diagnosed with intermittent claudication and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: vascular graft occlusion, . CILOSTAZOL dosage: 200 MG ORAL. During the same period patient was treated with PENTAERITHRITYL TETRANITRATE, PROCORALAN, PRETERAX, PANTOPRAZOLE, VALORON N RETARD, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Trasylol Side Effects Report #5460919-X
TRASYLOL problem was reported by a Physician from UNITED STATES on Mar 21, 2007. Female patient, 65 years of age, was diagnosed with coronary artery bypass and was treated with TRASYLOL. After drug was administered, patient experienced the following problems/side effects: vascular graft occlusion, . TRASYLOL dosage: unknown. Patient was hospitalized. Patient recovered.


Angiomax Side Effects Report #5331692-0
Physician from UNITED STATES reported ANGIOMAX problem on May 03, 2007. Male patient, 54 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: vascular graft occlusion, . ANGIOMAX dosage: 0.21 MG/KG, HR (MEAN INITIATION DOSE), INTRAVENOUS 0.2 MG/KG, HR (MAINTAINED MEAN DOSE), INTRAVENOUS. During the same period patient was treated with ARGATROBAN. Patient died.

Cilostazol Side Effects Report #5594652-0
CILOSTAZOL problem was reported by a Consumer or non-health professional from GERMANY on Jan 02, 2008. Female patient, 56 years of age, was diagnosed with intermittent claudication and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: compartment syndrome, vascular graft occlusion, . CILOSTAZOL dosage: 200 MG ORAL. During the same period patient was treated with FENTAERITHRITYL TETRANITRATE, PROCORALAN, PRETERAX, PANTOPRAZOLE, VALORON N, ASPIRIN. Patient recovered.

Plavix Side Effects Report #5618348-1
Physician from UNITED STATES reported PLAVIX problem on Mar 27, 2007. Male patient, 74 years of age, was diagnosed with coronary artery bypass and was treated with PLAVIX. After drug was administered, patient experienced the following problems/side effects: epistaxis, vascular graft occlusion, . PLAVIX dosage: 75 MG, QD, ORAL. During the same period patient was treated with ASPIRIN, BIBR. Patient recovered.

Cilostazol Side Effects Report #5535137-7
CILOSTAZOL problem was reported by a Physician from GERMANY on Nov 19, 2007. Female patient, 60 years of age, was diagnosed with intermittent claudication and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: post procedural complication, vascular graft occlusion, . CILOSTAZOL dosage: 50 MG/100 MG/200 MG, ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Trasylol Side Effects Report #5598081-5
Physician from SWEDEN reported TRASYLOL problem on Jan 16, 2008. Male patient, 75 years of age, was diagnosed with coronary artery bypass and was treated with TRASYLOL. After drug was administered, patient experienced the following problems/side effects: cardiac failure acute, medical device complication, vascular graft occlusion, . TRASYLOL dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHOTREXATE. Patient died on 10/30/2007.


Trasylol Side Effects Report #5507451-2
TRASYLOL problem was reported by a Physician from SWEDEN on Oct 31, 2007. Male patient, 75 years of age, was diagnosed with coronary artery bypass and was treated with TRASYLOL. After drug was administered, patient experienced the following problems/side effects: cardiac failure acute, medical device complication, vascular graft occlusion, . TRASYLOL dosage: unknown. During the same period patient was treated with PREDNISOLONE, METHOTREXATE. Patient died on 10/30/2007.

Aprotinin Side Effects Report #5266028-7
Pharmacist from UNITED STATES reported APROTININ problem on Mar 13, 2007. Female patient, 69 years of age, weighting 235.9 lb, was diagnosed with haemorrhage control and was treated with APROTININ. After drug was administered, patient experienced the following problems/side effects: post procedural myocardial infarction, urine output decreased, vascular graft occlusion, . APROTININ dosage: unknown. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about VASCULAR GRAFT OCCLUSION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about VASCULAR GRAFT OCCLUSION